SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054030
Filing Date
2021-11-03
Accepted
2021-11-03 17:01:09
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20210930.htm   iXBRL 10-Q 2641174
2 EX-31.1 vktx-ex311_8.htm EX-31.1 20484
3 EX-31.2 vktx-ex312_6.htm EX-31.2 20462
4 EX-32.1 vktx-ex321_7.htm EX-32.1 12589
  Complete submission text file 0001564590-21-054030.txt   9019413

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vktx-20210930.xsd EX-101.SCH 53685
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20210930_cal.xml EX-101.CAL 42660
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20210930_def.xml EX-101.DEF 175987
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20210930_lab.xml EX-101.LAB 411020
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20210930_pre.xml EX-101.PRE 317087
10 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10q_20210930_htm.xml XML 1790056
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 211376348
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences